Purchase Order 1333ND19PNB640732
- Not listed
- This is a firm fixed price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc. for the provision of Illumina library preparation and sequencing reagents/consumables. The contract has a ceiling value of $148,435.10 and a completion date of March 31, 2017. It is not a set-aside contract. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has provided similar goods and...
- This is a firm fixed-price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for a service agreement to provide Illumina HiSeq and MiSeq equipment, with a ceiling value of $87,393.52 and a completion date of September 15, 2021. The contract does not have a set-aside designation. Illumina is a for-profit organization and...
- This is a $141,129.90 firm fixed price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian agency, to Illumina, Inc. for the provision of an ILLUMINA MISEQ FGX sequencing system. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has provided similar products and services to support genomic research and diagnostics for federal agencies like the NIH, CDC,...
- This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The award, valued at $135,908.52, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics...
- This is a $90,997.20 firm fixed-price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the supply of an MISEQ I100 PLUS SYSTEM, with a period of performance running through December 12, 2025. This contract was not set aside for any specific business type. Illumina holds several other federal Indefinite...
- This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The delivery order, valued at $203,295.35, is for the supply of Illumina's proprietary sequencing instruments, reagents, and related products and services, to support the agency's genomic research and analysis needs. The contract has a...
- This is a firm fixed price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc. for the provision of sequencing instrument consumables. The contract has a total ceiling value of $94,539.25 and a period of performance through June 30, 2016. Illumina, a manufacturer of genetic sequencing instruments and reagents, has been a prime contractor on prior federal awards supporting genomic sequencing and analysis for...
- This is a $194,653.66 firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc. for the provision of sequencing instruments, reagents, and related services. The contract, which does not have a set-aside designation, supports Illumina's provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables, sample prep kits, sequencing chips, maintenance, and bioinformatics...
- This firm-fixed price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $120,084.75 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously been awarded prime federal contracts and subcontracts to support genomic sequencing and analysis across government agencies like the NIH, CDC, USDA, and VA. This...
The Department of Commerce National Institute of Standards and Technology (NIST) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of two (2) Illumina DNA sequencing instruments that are compatible with the validated protocols developed by NIST, in accordance with the stated requirements. The potential value of the contract is $100,878.00, and it was awarded on September 18, 2019 with a completion date of October 25, 2019. The contract has no set-aside designation. Illumina has previously provided a range of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), and Department of Veterans Affairs (VA). The company also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to provide sequencing platforms and supplies for the Naval Medical Research Center's Biological Defense Research Directorate.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.9k | 9/18/19 |